Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Clin Res Cardiol ; 113(4): 509-521, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37217802

RESUMO

OBJECTIVES: For patients with severe cardiopulmonary failure, such as cardiogenic shock, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is primarily utilized to preserve their life by providing continuous extracorporeal respiration and circulation. However, because of the complexity of patients' underlying diseases and serious complications, successful weaning from ECMO is often difficult. At present, there have been limited studies on ECMO weaning strategies, so the principal purpose of this meta-analysis is to examine how levosimendan contributes to the weaning of extracorporeal membrane oxygenation. METHODS: The Cochrane Library, Embase, Web of Science, and PubMed were browsed for all potentially related research about clinical benefits of levosimendan in weaning patients receiving VA-ECMO and included 15 of them. The main outcome is success of weaning from extracorporeal membrane oxygenation, with the secondary outcomes of 1-month mortality (28 or 30 days), ECMO duration, hospital or intensive care unit (ICU) length of stay, and use of vasoactive drugs. RESULTS: 1772 patients altogether from 15 publications were incorporated in our meta-analysis. We used fixed and random-effect models to combine odds ratio (OR) and 95% confidence interval (CI) for dichotomous outcomes and standardized mean difference (SMD) for continuous outcomes. The weaning success rate in the levosimendan group was considerably higher in contrast to the comparison (OR = 2.78, 95% CI 1.80-4.30; P < 0.00001; I2 = 65%), and subgroup analysis showed that there was less heterogeneity in patients after cardiac surgery (OR = 2.06, 95% CI, 1.35-3.12; P = 0.0007; I2 = 17%). In addition, the effect of levosimendan on improving weaning success rate was statistically significant only at 0.2 mcg/kg/min (OR = 2.45, 95% CI, 1.11-5.40; P = 0.03; I2 = 38%). At the same time, the 28-day or 30-day proportion of deaths in the sample receiving levosimendan also decreased (OR = 0.47, 95% CI, 0.28-0.79; P = 0.004; I2 = 73%), and the difference was statistically significant. In terms of secondary outcomes, we found that individuals undergoing levosimendan treatment had a longer duration of VA-ECMO support. CONCLUSIONS: In patients receiving VA-ECMO, levosimendan treatment considerably raised the weaning success rate and helped lower mortality. Since most of the evidence comes from retrospective studies, more randomized multicenter trials are required to verify the conclusion.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Oxigenação por Membrana Extracorpórea , Humanos , Simendana/uso terapêutico , Oxigenação por Membrana Extracorpórea/efeitos adversos , Estudos Retrospectivos , Choque Cardiogênico
2.
Front Pharmacol ; 13: 1033982, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36545321

RESUMO

The cyclic GMP-AMP synthase-stimulator of interferon genes signal transduction pathway is critical in innate immunity, infection, and inflammation. In response to pathogenic microbial infections and other conditions, cyclic GMP-AMP synthase (cGAS) recognizes abnormal DNA and initiates a downstream type I interferon response. This paper reviews the pathogenic mechanisms of stimulator of interferon genes (STING) in different organs, including changes in fibrosis-related biomarkers, intending to systematically investigate the effect of the cyclic GMP-AMP synthase-stimulator of interferon genes signal transduction in inflammation and fibrosis processes. The effects of stimulator of interferon genes in related auto-inflammatory and neurodegenerative diseases are described in this article, in addition to the application of stimulator of interferon genes-related drugs in treating fibrosis.

3.
IEEE Trans Image Process ; 31: 392-404, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34874855

RESUMO

RGBT tracking receives a surge of interest in the computer vision community, but this research field lacks a large-scale and high-diversity benchmark dataset, which is essential for both the training of deep RGBT trackers and the comprehensive evaluation of RGBT tracking methods. To this end, we present a La rge- s cale H igh-diversity [Formula: see text]nchmark for short-term R GBT tracking (LasHeR) in this work. LasHeR consists of 1224 visible and thermal infrared video pairs with more than 730K frame pairs in total. Each frame pair is spatially aligned and manually annotated with a bounding box, making the dataset well and densely annotated. LasHeR is highly diverse capturing from a broad range of object categories, camera viewpoints, scene complexities and environmental factors across seasons, weathers, day and night. We conduct a comprehensive performance evaluation of 12 RGBT tracking algorithms on the LasHeR dataset and present detailed analysis. In addition, we release the unaligned version of LasHeR to attract the research interest for alignment-free RGBT tracking, which is a more practical task in real-world applications. The datasets and evaluation protocols are available at: https://github.com/mmic-lcl/Datasets-and-benchmark-code.

4.
Biosci Biotechnol Biochem ; 84(9): 1856-1860, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32471327

RESUMO

CD142 promotes cell mobility, which contributes to carcinogenesis. However, the role of CD142 on colorectal cancer (CRC) mobility is unclear. This study showed that CD142 expression increased in CRC tissues, especially in those with invasion or metastasis. The positive sorting or overexpression of CD142 promoted the invasion and migration of CRC cells. Overall, CD142 may be responsible for CRC mobility.


Assuntos
Movimento Celular , Neoplasias Colorretais/patologia , Tromboplastina/metabolismo , Linhagem Celular Tumoral , Regulação Neoplásica da Expressão Gênica , Humanos , Invasividade Neoplásica , Metástase Neoplásica
5.
Chemosphere ; 248: 126053, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32041067

RESUMO

Nitrogen-containing carbon materials (NCC-x) are promising metal-free catalysts for activation of peroxymonosulfate (PMS) to treat with aqueous organic pollutants. In this study, NCC-x were synthesized via a facile thermal polymerization method using urea and terephthalaldehyde as precursors. This method was derived from the polymerization method of graphitic carbon nitride (g-C3N4) and the reaction between the precursors was based on Schiff base chemistry. Compared with the synthesis of g-C3N4 using urea as the precursor, formation of a melamine ring was inhibited and the cyano groups were produced in NCC-x during the polymerization process. The obtained NCC-x catalysts had high specific surface areas, many graphite-nitrogen active sites, and high degrees of graphitization, thus exhibiting excellent activities for the degradation of bisphenol A via PMS activation. This study introduces a convenient method to obtain a highly efficient nitrogen-containing carbon PMS activator and the results are useful for the development of bisphenol A treatment by PMS activation using carbon-containing materials.


Assuntos
Compostos Benzidrílicos/química , Nitrogênio/química , Peróxidos/química , Fenóis/química , Carbono/química , Catálise , Poluentes Ambientais , Grafite , Metais , Compostos de Nitrogênio , Polimerização , Água
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA